Kyverna Therapeutics, Inc. KYTX Unpaid Deferred Offering Costs Included In Accounts Payable And Other Accrued Expenses And Current Liabilities
Other financials
Where this comes from
Reported directly by Kyverna Therapeutics, Inc. in its filing.
Tagged under the XBRL concept kytx:UnpaidDeferredOfferingCostsIncludedInAccountsPayableAndOtherAccruedExpensesAndCurrentLiabilities.
The official record: Kyverna Therapeutics, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Kyverna Therapeutics, Inc.'s unpaid deferred offering costs included in accounts payable and other accrued expenses and current liabilities.
Connect your AI assistant and see it in context, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Kyverna Therapeutics, Inc.'s unpaid deferred offering costs included in accounts payable and other accrued expenses and current liabilities?
- Kyverna Therapeutics, Inc. (KYTX) reported unpaid deferred offering costs included in accounts payable and other accrued expenses and current liabilities of $123K in Q1 2026.